| 产品名称： | Porcine respiratory coronavirus |
|---|---|
| 商品货号： | TS193080 |
| Classification： | Coronaviridae, Alphacoronavirus, Alphacoronavirus 1 |
| Agent： | Porcine respiratory coronavirus |
| Strain： | AR310 |
| Applications： | This strain provides a biological pure culture of a novel pathogenic porcine respiratory coronavirus (PRCV) and a vaccine derived therefrom effective against PRCV infection and transmissible gastroenteritis virus (TGEV) infection. The virus produces moderate pneumonia in pigs, there is no indication of human health hazard. |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen 1.0 mL |
| Storage Conditions： | -70°C or colder |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Images： |  |
| Comments： | This strain provides a biological pure culture of a novel pathogenic porcine respiratory coronavirus (PRCV) and a vaccine derived therefrom effective against PRCV infection and Transmissible gastroenteritis virus (TGEV) infection.xa0 The virus produces a moderate pneumonia in pigs.xa0 There is no indication of human health hazard. This material is cited in U.S. and/or other patent # 5,419,907 May 30, 1995. |
| Effect on Host： | CPE, fused and rounded cells with sloughing |
| Recommended Host： |
ST cells (ATCC® CRL-1746™)
|
| Growth Conditions： | Temperature: 37°C Recommendations for Infection: For best results, infection should be performed on a 80-90% confluent, 18-48 hour old cellular monolayer. Prepare dilution of virus in minimum amount of volume (e.g. 1 mL per 25 cm2). Wash monolayer with PBS or serum free medium prior to inoculation. Adsorb virus dilution for 1-2 hours at 37°C in a humidified 5% CO2 atmosphere, rocking every 20-30 minutes to redistribute inoculum. End adsorption by adding virus growth medium.
Incubation:xa02-3 days at 37°C in a humidified 5% CO2 atmosphere, until CPE is progressed through 80% of the monolayer. |
| Name of Depositor： | Iowa State University Research Foundation |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Special Collection： | ATCC |
| Source： | Culture of a novel TGEV-related Porcine respiratory coronavirus |
| References： | Paul PS, et al. Pathogenic porcine respiratory coronavirus. US Patent 5,419,907 dated May 30 1995 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Porcine respiratory coronavirus |
|---|---|
| 商品货号： | TS193080 |
| Classification： | Coronaviridae, Alphacoronavirus, Alphacoronavirus 1 |
| Agent： | Porcine respiratory coronavirus |
| Strain： | AR310 |
| Applications： | This strain provides a biological pure culture of a novel pathogenic porcine respiratory coronavirus (PRCV) and a vaccine derived therefrom effective against PRCV infection and transmissible gastroenteritis virus (TGEV) infection. The virus produces moderate pneumonia in pigs, there is no indication of human health hazard. |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen 1.0 mL |
| Storage Conditions： | -70°C or colder |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Images： | |
| Comments： | This strain provides a biological pure culture of a novel pathogenic porcine respiratory coronavirus (PRCV) and a vaccine derived therefrom effective against PRCV infection and Transmissible gastroenteritis virus (TGEV) infection.xa0 The virus produces a moderate pneumonia in pigs.xa0 There is no indication of human health hazard. This material is cited in U.S. and/or other patent # 5,419,907 May 30, 1995. |
| Effect on Host： | CPE, fused and rounded cells with sloughing |
| Recommended Host： |
ST cells (ATCC® CRL-1746™)
|
| Growth Conditions： | Temperature: 37°C Recommendations for Infection: For best results, infection should be performed on a 80-90% confluent, 18-48 hour old cellular monolayer. Prepare dilution of virus in minimum amount of volume (e.g. 1 mL per 25 cm2). Wash monolayer with PBS or serum free medium prior to inoculation. Adsorb virus dilution for 1-2 hours at 37°C in a humidified 5% CO2 atmosphere, rocking every 20-30 minutes to redistribute inoculum. End adsorption by adding virus growth medium.
Incubation:xa02-3 days at 37°C in a humidified 5% CO2 atmosphere, until CPE is progressed through 80% of the monolayer. |
| Name of Depositor： | Iowa State University Research Foundation |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Special Collection： | ATCC |
| Source： | Culture of a novel TGEV-related Porcine respiratory coronavirus |
| References： | Paul PS, et al. Pathogenic porcine respiratory coronavirus. US Patent 5,419,907 dated May 30 1995 |
